Education
About Us
Working with TipRanks
Follow Us
Microba Life Sciences Limited (AU:MAP)
ASX:MAP
Total Valuation
Microba Life Sciences Limited has a market cap or net worth of AU$45.67M. The enterprise value is AU$29.64M.
Market CapAU$45.67M
Enterprise ValueAU$29.64M
Share Statistics
Microba Life Sciences Limited has 608,963,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding608,963,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Microba Life Sciences Limited’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -62.66%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-62.66%
Return on Capital Employed (ROCE)-0.66
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.33
Inventory Turnover4.25
Valuation Ratios
The current PE Ratio of Microba Life Sciences Limited is ―. Microba Life Sciences Limited’s PEG ratio is 0.08.
PE Ratio―
PS Ratio2.43
PB Ratio1.17
Price to Fair Value1.17
Price to FCF-2.56
Price to Operating Cash Flow-2.65
PEG Ratio0.08
Income Statement
In the last 12 months, Microba Life Sciences Limited had revenue of 15.67M and earned -14.94M in profits. Earnings per share was -0.03.
Revenue15.67M
Gross Profit7.44M
Operating Income-24.61M
Pretax Income-15.05M
Net Income-14.94M
EBITDA-10.51M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -12.01M and capital expenditures -326.39K, giving a free cash flow of -12.34M billion.
Operating Cash Flow-12.01M
Free Cash Flow-12.34M
Free Cash Flow per Share-0.02
Dividends & Yields
Microba Life Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change-71.15%
50-Day Moving Average0.08
200-Day Moving Average0.11
Relative Strength Index (RSI)56.49
Average Volume (3m)469.77K
Important Dates
Microba Life Sciences Limited upcoming earnings date is Mar 4, 2026, Before Open (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Microba Life Sciences Limited as a current ratio of 1.87, with Debt / Equity ratio of 9.94%
Current Ratio1.87
Quick Ratio1.68
Debt to Market Cap0.03
Net Debt to EBITDA0.81
Interest Coverage Ratio-139.28
Taxes
In the past 12 months, Microba Life Sciences Limited has paid -106.59K in taxes.
Income Tax-106.59K
Effective Tax Rate<0.01
Enterprise Valuation
Microba Life Sciences Limited EV to EBITDA ratio is -2.82, with an EV/FCF ratio of -1.99.
EV to Sales1.89
EV to EBITDA-2.82
EV to Free Cash Flow-1.99
EV to Operating Cash Flow-2.46
Balance Sheet
Microba Life Sciences Limited has AU$11.74M in cash and marketable securities with AU$3.23M in debt, giving a net cash position of AU$8.51M billion.
Cash & Marketable SecuritiesAU$11.74M
Total DebtAU$3.23M
Net CashAU$8.51M
Net Cash Per ShareAU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is 47.49%, with operating margin of -157.05%, and net profit margin of -95.34%.
Gross Margin47.49%
Operating Margin-157.05%
Pretax Margin-96.02%
Net Profit Margin-95.34%
EBITDA Margin-67.08%
EBIT Margin-95.36%
Analyst Forecast
The average price target for Microba Life Sciences Limited is AU$0.14, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.14
Price Target Upside75.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast29.60%
EPS Growth Forecast33.00%